- Home
- PROK
PROK
ProKidney Corp.
as 11-11-2025 3:43pm EST
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | WINSTON-SALEM |
| Market Cap: | 417.1M | IPO Year: | N/A |
| Target Price: | $6.25 | AVG Volume (30 days): | 1.5M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.46 - $7.13 | Next Earning Date: | 11-10-2025 |
| Revenue: | $744,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 471.74% | Revenue Growth (next year): | -75.49% |
Latest ProKidney Corp. News
PROK Breaking Stock News: Dive into PROK Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
GlobeNewswire
6 days ago
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
GlobeNewswire
14 days ago
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
Simply Wall St.
a month ago
Discovering Potential: IZEA Worldwide And 2 Other Top Penny Stocks
GlobeNewswire
6 months ago
ProKidney Reports First Quarter 2025 Financial Results and Business Highlights
Argus Research
7 months ago
Daily – Vickers Top Buyers & Sellers for 04/25/2025
Argus Research
7 months ago
Daily – Vickers Top Buyers & Sellers for 04/22/2025
Argus Research
7 months ago
Daily – Vickers Top Buyers & Sellers for 04/21/2025
Compare PROK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PROK ProKidney Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.